Podcast: ATTR-CM: What do we know about blood levels of the TTR protein? A discussion with experts
Therapeutic Advances in Cardiovascular Disease
Published online on April 02, 2026
Abstract
Therapeutic Advances in Cardiovascular Disease, Volume 20, January-December 2026.
Transthyretin (TTR) amyloid cardiomyopathy occurs when stable TTR, normally a 4-protein tetramer, becomes misfolded and aggregates to form amyloid fibrils that accumulate in the heart. Progressive accumulation causes cardiomyopathy, leading to arrhythmia ...
Transthyretin (TTR) amyloid cardiomyopathy occurs when stable TTR, normally a 4-protein tetramer, becomes misfolded and aggregates to form amyloid fibrils that accumulate in the heart. Progressive accumulation causes cardiomyopathy, leading to arrhythmia ...